Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ri...
Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
Omgene is a diligent, focussed, and target oriented organization aspiring to be an inspiring presence in the pharmaceutical space. Our core objective is to build a healthier world. The platform of our performance and success ...
Omgene is a diligent, focussed, and target oriented organization aspiring to be an inspiring presence in the pharmaceutical space. Our core objective is to build a healthier world. The platform of our performance and success is our vision to be a biopharmaceutical company with a special niche in global peptide scenario, delivering on our promise to our patients, clients, investors, and our employees.
Established in 2011, as a private limited company registered under Companies Act, 1956, we are quickly growing towards creating a vast impact on the healthcare industry.